CD34 may be used to determine the adequacy of a stem cell harvest for hematologic recovery following high dose chemotherapy.

T. M. Zimmerman*, W. J. Lee, J. G. Bender, R. Mick, S. F. Williams

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)303-308
Number of pages6
JournalProgress in clinical and biological research
StatePublished - 1994

ASJC Scopus subject areas

  • Medicine(all)

Cite this